Most recently, it's been discovered that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in comparable places as classical opioid receptors, it binds to the big range of endogenous opioids. Compared with most opioid receptors, this receptor acts to be a scavenger https://carola703bwp0.ageeksblog.com/profile